from Washington Post2 years agoThe pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent. Read at Washington Post[add][|| ... ]